Naloxegol US PMR CV Safety.

Trial Identifier: D3820R00008
Sponsor: AstraZeneca
NCTID:: NCT02813356
Start Date: June 2016
Primary Completion Date: December 2023
Condition: Digestive & Intestinal - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
USA, DE Wilmington, DE, USA, 19803
USA, IL Hines, IL, USA, 60141